ATE358474T1 - Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung - Google Patents

Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung

Info

Publication number
ATE358474T1
ATE358474T1 AT02711967T AT02711967T ATE358474T1 AT E358474 T1 ATE358474 T1 AT E358474T1 AT 02711967 T AT02711967 T AT 02711967T AT 02711967 T AT02711967 T AT 02711967T AT E358474 T1 ATE358474 T1 AT E358474T1
Authority
AT
Austria
Prior art keywords
halopohalite
sodium
taurine
halogen
production
Prior art date
Application number
AT02711967T
Other languages
English (en)
Inventor
Arnaud Mainnemare
Original Assignee
Arnaud Mainnemare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arnaud Mainnemare filed Critical Arnaud Mainnemare
Application granted granted Critical
Publication of ATE358474T1 publication Critical patent/ATE358474T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Glass Compositions (AREA)
AT02711967T 2001-01-23 2002-01-16 Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung ATE358474T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0100862A FR2819723B1 (fr) 2001-01-23 2001-01-23 Composition halogene, son procede de preparation et ses utilisations

Publications (1)

Publication Number Publication Date
ATE358474T1 true ATE358474T1 (de) 2007-04-15

Family

ID=8859119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02711967T ATE358474T1 (de) 2001-01-23 2002-01-16 Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung

Country Status (13)

Country Link
US (3) US20040022871A1 (de)
EP (1) EP1401422B1 (de)
JP (3) JP2004519462A (de)
AT (1) ATE358474T1 (de)
AU (1) AU2002231889A1 (de)
CA (1) CA2435419C (de)
CY (1) CY1106704T1 (de)
DE (1) DE60219314T2 (de)
DK (1) DK1401422T3 (de)
ES (1) ES2284837T3 (de)
FR (1) FR2819723B1 (de)
PT (1) PT1401422E (de)
WO (1) WO2002058692A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2819723B1 (fr) * 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
SE0103766D0 (sv) * 2001-11-09 2001-11-09 Astrazeneca Ab Novel assay
AR039385A1 (es) * 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
MXPA06001898A (es) 2003-08-18 2006-05-31 Novacal Pharmaceuticals Inc Aminoacidos n, n-dihalogenados y sus derivados.
SE0302756D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel Compounds
SE0402591D0 (sv) * 2004-10-25 2004-10-25 Astrazeneca Ab Novel use
MY140748A (en) * 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
TWI432231B (zh) * 2005-10-06 2014-04-01 Novabay Pharmaceuticals Inc 使用ｎ-鹵化胺基酸於預防包括泌尿道感染（ｕｔｉ）之細菌性與真菌性感染的系統與方法
TW200804383A (en) * 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
US20080288019A1 (en) * 2007-01-31 2008-11-20 Adam Heller Electrochemical management of pain
WO2009126912A1 (en) * 2008-04-10 2009-10-15 Novabay Pharmaceuticals, Inc. Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
US20110091570A1 (en) * 2008-04-15 2011-04-21 Waldemar Gottardi Compositions and Devices for Antisepsis and Anticoagulation
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
CN103747770A (zh) 2011-06-15 2014-04-23 Rls全球股份公司 龋牙本质组织的检测和除去
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
EP2950777B1 (de) * 2013-01-30 2021-06-23 Straumann Holding AG Zahnfleischerkrankungsbehandlung
FR3009196B1 (fr) * 2013-08-02 2015-10-02 Arnaud Mainnemare Nouvelle composition pour le traitement de l'inflammation
PT3469117T (pt) 2016-06-09 2022-03-08 De Nora Holdings Us Inc Produção eletrolítica de soluções de cloramina orgânica
RU2624166C1 (ru) * 2016-07-29 2017-06-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) Способ лечения деструктивных форм хронических верхушечных периодонтитов
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012842A (en) * 1972-06-12 1977-03-22 National Patent Development Corporation Dental treatment method and apparatus
US3998945A (en) * 1972-06-12 1976-12-21 National Patent Development Corporation Dental treatment
CA1025705A (en) 1972-06-12 1978-02-07 Jaroslav Vit Method and apparatus for removal of dental plaque and caries by means of high velocity pulsating jet of liquid
US4035483A (en) * 1973-05-29 1977-07-12 John Bunyan Antiseptic and non-toxic substance and a method of making the same
DE4041703C2 (de) * 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) * 1994-01-13 2006-03-29 相互薬工株式会社 殺菌剤
DE19712565A1 (de) * 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
JPH11279057A (ja) 1998-03-30 1999-10-12 Arimasa Miyamoto ＮＦκＢ活性化阻害剤
DE19816102C1 (de) * 1998-04-10 1999-09-16 Waldemar Gottardi Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
JP5209159B2 (ja) * 1999-06-04 2013-06-12 ボストン サイエンティフィック サイムド，インコーポレイテッド 抗感染性装置およびその製造方法
FR2819723B1 (fr) * 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
JP4948846B2 (ja) 2006-02-08 2012-06-06 株式会社東芝 突入電流抑制回路を備えた電源装置

Also Published As

Publication number Publication date
EP1401422A2 (de) 2004-03-31
ES2284837T3 (es) 2007-11-16
US7879366B2 (en) 2011-02-01
JP2013189477A (ja) 2013-09-26
JP2004519462A (ja) 2004-07-02
FR2819723B1 (fr) 2006-11-17
US20110091578A1 (en) 2011-04-21
EP1401422B1 (de) 2007-04-04
WO2002058692A2 (fr) 2002-08-01
US8709498B2 (en) 2014-04-29
AU2002231889A1 (en) 2002-08-06
US20090022815A1 (en) 2009-01-22
DK1401422T3 (da) 2007-08-06
DE60219314D1 (de) 2007-05-16
DE60219314T2 (de) 2008-01-03
PT1401422E (pt) 2007-07-09
WO2002058692A3 (fr) 2003-12-24
JP2010174050A (ja) 2010-08-12
US20040022871A1 (en) 2004-02-05
CY1106704T1 (el) 2012-05-23
WO2002058692A9 (fr) 2003-03-06
FR2819723A1 (fr) 2002-07-26
CA2435419A1 (fr) 2002-08-01
CA2435419C (fr) 2012-06-05

Similar Documents

Publication Publication Date Title
ATE358474T1 (de) Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung
DE69933208D1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
DK1898876T3 (da) Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
DE602004030353D1 (de) Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
CY1114133T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
ECSP055844A (es) Nuevos compuestos triciclicos
DE60213404D1 (de) Verwendung von sulodexid zur behandlung von reizdarm
TR200200716T2 (tr) Ketiyapin granülleri
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
ATE273682T1 (de) Topische formulierungen, die hautpenetrations- mittel enthalten, und ihre verwendung
BR9814867A (pt) Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
CY1107346T1 (el) Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401422

Country of ref document: EP